Company Encyclopedia
View More
name
Basel Medical
BMGL.US
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman’s health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments.
386.28 B
BMGL.USMarket value -Rank by Market Cap -/-

Financial Score

12/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking51/77
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-194.61%E
    • Profit Margin-99.84%E
    • Gross Margin26.29%C
  • Growth ScoreC
    • Revenue YoY18.97%B
    • Net Profit YoY-698.04%E
    • Total Assets YoY9.79%B
    • Net Assets YoY-31.66%E
  • Cash ScoreC
    • Cash Flow Margin-100.16%D
    • OCF YoY18.97%B
  • Operating ScoreB
    • Turnover0.73B
  • Debt ScoreD
    • Gearing Ratio71.14%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    12 Health Care Stocks Moving In Friday's Intraday Session

    During Friday's intraday session, cbdMD (AMEX:YCBD) stock surged by 104.4%, while Canopy Growth (NASDAQ:CGC) rose 37.16%. Climb Bio (NASDAQ:CLYM) and Basel Medical Group (NASDAQ:BMGL) also saw significant gains. Conversely, Applied Therapeutics (NASDAQ:APLT) shares plummeted 44.2%, and Milestone Pharmaceuticals (NASDAQ:MIST) fell 37.69%. Other notable decliners included Tenaya Therapeutics (NASDAQ:TNYA) and WORK Medical Tech Gr (NASDAQ:WOK).

    benzinga_article·
    US
    CGC
    +53.98%
    US
    BMGL
    +30.92%
    US
    MIST
    -18.31%
    benzinga_article·
    US
    CGC
    +53.98%
    US
    BMGL
    +30.92%
    US
    MIST
    -18.31%

    Basel Medical Group Opens New Orthopaedic Clinic in Novena

    Basel Medical Group Ltd. has opened a new Singapore Sports & Orthopaedic Clinic at Mount Elizabeth Novena Specialist Centre. This expansion aims to improve access to orthopaedic and sports-medicine care in Singapore, offering services like musculoskeletal injury treatment and joint replacement. The clinic supports Basel's growth strategy amid rising demand from aging and active populations.

    Reuters·
    US
    BMGL
    +30.92%
    Reuters·
    US
    BMGL
    +30.92%

    Basel Medical Group Misses Deadline for Annual Financial Report

    Basel Medical Group Ltd. missed the deadline for its annual financial report, receiving a Nasdaq notification for not including an auditor’s opinion in its Form 20-F for the fiscal year ended June 30, 2025. The company has 60 days to submit a compliance plan, with a possible extension of up to 180 days. Trading on Nasdaq remains unaffected.

    Reuters·
    US
    BMGL
    +30.92%
    Reuters·
    US
    BMGL
    +30.92%

    Basel Medical Group Ltd. revenue rises 12.6% to S$11.3 million for fiscal 2025

    Basel Medical Group Ltd. reported a 12.6% increase in revenue to S$11.3 million for fiscal 2025, driven by the acquisition of a general practitioners clinic group and growth in its orthopedic clinic. Net cash used in operations was S$3.4 million, while financing activities generated S$13.3 million. Cash at year-end was S$3.0 million. Directors confirmed sufficient working capital for at least 12 months.

    Reuters·
    US
    BMGL
    +30.92%
    Reuters·
    US
    BMGL
    +30.92%

    Basel Medical Group Delays Annual Financial Report Filing

    Basel Medical Group Ltd. has announced a delay in filing its Annual Report on Form 20-F for the fiscal year ended June 30, 2025. The company requires additional time to finalize its consolidated financial statements and complete audit procedures, expecting to file the report within fifteen days of the original deadline.

    Reuters·
    US
    BMGL
    +30.92%
    Reuters·
    US
    BMGL
    +30.92%
    © 2025 Longbridge｜Disclaimer